Close Menu

NEW YORK (360Dx) – T2 Biosystems announced today that it has received a grant worth up to $2 million by CARB-X in order to accelerate the development of new tests to identify bacterial pathogens and resistance markers. The new tests will increase the T2Dx instrument product line by detecting 20 additional bacterial species and resistance targets in whole blood samples, with a focus on blood-borne pathogens on the US Centers for Disease Control and Prevention's antibiotic resistance threat list.

To read the full story....

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.

Don't have a 360Dx or GenomeWeb account?
Register for Free.